1. Home
  2. SNOA vs CISS Comparison

SNOA vs CISS Comparison

Compare SNOA & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • CISS
  • Stock Information
  • Founded
  • SNOA 1999
  • CISS 2022
  • Country
  • SNOA United States
  • CISS Greece
  • Employees
  • SNOA N/A
  • CISS N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • CISS Marine Transportation
  • Sector
  • SNOA Health Care
  • CISS Consumer Discretionary
  • Exchange
  • SNOA Nasdaq
  • CISS Nasdaq
  • Market Cap
  • SNOA 6.5M
  • CISS 5.3M
  • IPO Year
  • SNOA 2007
  • CISS N/A
  • Fundamental
  • Price
  • SNOA $3.16
  • CISS $1.58
  • Analyst Decision
  • SNOA
  • CISS
  • Analyst Count
  • SNOA 0
  • CISS 0
  • Target Price
  • SNOA N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • SNOA 30.5K
  • CISS 99.3K
  • Earning Date
  • SNOA 11-04-2025
  • CISS 11-18-2025
  • Dividend Yield
  • SNOA N/A
  • CISS N/A
  • EPS Growth
  • SNOA N/A
  • CISS N/A
  • EPS
  • SNOA N/A
  • CISS N/A
  • Revenue
  • SNOA $16,937,000.00
  • CISS $33,613,149.00
  • Revenue This Year
  • SNOA $23.00
  • CISS N/A
  • Revenue Next Year
  • SNOA $24.59
  • CISS N/A
  • P/E Ratio
  • SNOA N/A
  • CISS $60.64
  • Revenue Growth
  • SNOA 25.02
  • CISS N/A
  • 52 Week Low
  • SNOA $1.75
  • CISS $1.46
  • 52 Week High
  • SNOA $6.92
  • CISS $13.38
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 39.10
  • CISS 34.46
  • Support Level
  • SNOA $3.25
  • CISS $1.46
  • Resistance Level
  • SNOA $3.57
  • CISS $1.81
  • Average True Range (ATR)
  • SNOA 0.22
  • CISS 0.15
  • MACD
  • SNOA -0.03
  • CISS -0.02
  • Stochastic Oscillator
  • SNOA 29.37
  • CISS 22.03

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.

Share on Social Networks: